Generate Biomedicines, Inc. (GENB) Live Share Price, Invest From India

Generate Biomedicines, Inc. Stock Performance

as on November 11, 2026 at 7:24 am IST

Day's Low
Day's High
$13.63
Day's Price Range
$14.54
$13.84
1.52%
Downside
5.06%
Upside
52 Week's Low
52 Week's High
52-Week Price Range
$13.84
100.00%
Downside
-100.00%
Upside

Generate Biomedicines, Inc. share price movements today

Previous Close: $14.18
Open: $14.00
Volume: 415.9K
Market Cap: $1.7B
Day's Low - High: $13.63 - $14.54

Generate Biomedicines, Inc. Historical Returns

1 Month Return: -1.12 %
3 Month Return: -3.67 %
1 Year Return: 0 %
3 Year Return: 0 %
5 Year Return: 0 %

Generate Biomedicines, Inc. Stock Fundamentals & Key Indicators

Check Generate Biomedicines, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.7B

EPS (TTM)

-1.06

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-7.73

Industry PE ratio

-7.60

PEG Ratio

-0.08

EBITDA

-124.7M

Revenue (TTM)

13.5M

Profit Margin

86.17%

Return On Equity TTM

-153.12%

Generate Biomedicines, Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Generate Biomedicines, Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Generate Biomedicines, Inc.	StrongBuy	$1.7B	NA	-7.73	86.17%	0.00%
Moderna	Neutral	$101.5B	17.49%	-35.95	28.00%	0.00%
BeOne Medicines	StrongBuy	$46.5B	NA	66.55	88.39%	0.00%
Vertex Pharmaceuticals	StrongBuy	$138.7B	193.16%	34.94	85.57%	0.00%
Regeneron	Buy	$93.5B	47.86%	19.26	85.77%	0.41%

Analyst Recommendation on Generate Biomedicines, Inc. Stock

Based on 3 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 3 analysts, 100% of analysts recommend a 'BUY' rating for Generate Biomedicines, Inc.. Average target price of $26

Generate Biomedicines, Inc. Share Price Target

Get share price movements and forecasts by analysts on Generate Biomedicines, Inc..

Current Price

$13.84

Analyzed by

3 Analysts

High

$30

Low

$22

Generate Biomedicines, Inc. target price $0, a slight upside of 0% compared to current price of $13.84. According to 3 analysts rating.

Indian Investors' Interest in Generate Biomedicines, Inc. Stock

Search interest for Generate Biomedicines, Inc. Stock has decreased by -48% in the last 30 days, reflecting a downward trend in search activity.

Time period: October 12, 2026 to November 11, 2026

Change:-48% versus previous 30 day period

Generate Biomedicines, Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2025	Mar 2026	Jun 2026
Total Revenue	8	7	6
Gross Profit	8	3	6
Operating Income	-48	-64	-71
EBITDA	-40	-60	-63
Interest Expense	0	0	0
Depreciation	3	3	3
Income Before Tax	-44	-61	-67
Income Tax Expense	0	0	0
Net Income	-41	-61	-67
Net Profit Margin	100.00%	54.69%	100.00%

Generate Biomedicines, Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2024	Dec 2025
Total Revenue	20	31
Gross Profit	20	31
Operating Income	-196	-235
EBITDA	-163	-208
Interest Expense	2	1
Depreciation	15	13
Income Before Tax	-181	-222
Income Tax Expense	0	0
Net Income	-173	-203
Net Profit Margin	100.00%	100.00%

Generate Biomedicines, Inc. Quarterly Cash Flow

All numbers in Millions USD

	Mar 2025	Mar 2026	Jun 2026
Net Income	-44	-61	-67
Operating Cash Flow	-53	-80	-57
Investing Cash Flow	75	-252	33
Financing Cash Flow	20	371	0
Change in Cash	42	160	-25

Generate Biomedicines, Inc. Annual Cash Flow

All numbers in Millions USD

	Dec 2024	Dec 2025
Net Income	-181	-222
Operating Cash Flow	-117	-200
Investing Cash Flow	-57	116
Financing Cash Flow	91	28
Change in Cash	-84	-55

Global Institutional Holdings in Generate Biomedicines, Inc.

Check out the Institutions with significant holdings in Generate Biomedicines, Inc..

Funds	Holdings
Noubar Afeyan	48.83%
SMALLCAP World Fund Inc	2.92%
Fidelity Mt. Vernon Street Trust	2.68%
Michael Nally	2.25%
Vanguard	1.82%

See all

Insights on Generate Biomedicines, Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 7 days, GENB stock has moved up by 2.4%

About Generate Biomedicines, Inc.

Generate Biomedicines, Inc. is a U.S.-based company pioneering generative biology, leveraging machine learning for the discovery and advancement of novel protein therapeutics. Their core approach involves developing drugs using protein-based modalities. The company's pipeline includes several key candidates: GB-0895, an investigational long-acting anti-TSLP monoclonal antibody designed for bi-annual dosing in severe asthma; GB-4362, an MMAE payload neutralizer monoclonal antibody; and GB-5267, a MUC16 CAR-T cell therapy. Integral to their work is the Generate Platform, a sophisticated system engineered to be versatile across diverse therapeutic areas and protein modalities. This platform combines computational innovation with scalable biohardware, allowing them to tackle therapeutic hurdles beyond the capabilities of traditional technologies. Established in 2018, the company was initially known as Generate Biologics, Inc. before rebranding to Generate Biomedicines, Inc. in February 2020. Its headquarters are located in Somerville, Massachusetts.

Organisation	Generate Biomedicines, Inc.
Headquarters	101 South Street, Somerville, MA, 02143, US
Industry	Biotechnology
CEO	Michael T. Nally

Key Management of Generate Biomedicines, Inc.

Name	Title
Dr. Gevorg Grigoryan Ph.D.	Co-Founder & CTO
Dr. Aarif Khakoo M.B.A., M.D.	Chief Scientific Officer
Mr. Sean B. W. Martin J.D.	Secretary, Chief Legal Officer & General Counsel
Ms. Beth Grous	Chief People Officer
Dr. Daria Hazuda Ph.D.	Senior Vice President of Discovery Strategy
Mr. Sahm Nasseri M.B.A.	Senior Vice President of Business Development & Strategy
Dr. Noubar B. Afeyan Ph.D.	Co-founder & Independent Chair of the Board
Mr. Michael T. Nally M.B.A.	CEO & Director
Dr. Jason E. Silvers J.D., M.D.	President & CFO
Ms. Molly Gibson Ph.D.	Co-Founder

FAQs

What is Generate Biomedicines, Inc. share price today?

Generate Biomedicines, Inc. share price today is $13.84 as on November 11, 2026 at 1:54 am IST. Generate Biomedicines, Inc. share today touched a day high of $14.54 and a low of $13.63.

What is the 52 week high and 52 week low for Generate Biomedicines, Inc. share?

Generate Biomedicines, Inc. share touched a 52 week high of $0.00 on January 1, 1970 and a 52 week low of $0.00 on January 1, 1970. Generate Biomedicines, Inc. stock price today i.e. November 11, 2026 at 1:54 am IST is trending at $13.84,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.

What is Generate Biomedicines, Inc.'s market capitalisation today?

Generate Biomedicines, Inc. market capitalisation is $0.00T as on November 11, 2026 at 1:54 am IST.

How to invest in Generate Biomedicines, Inc. Stock (GENB) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Generate Biomedicines, Inc. on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Generate Biomedicines, Inc. Stock (GENB) from India?

Indian investors can start investing in Generate Biomedicines, Inc. (GENB) shares with as little as ₹93.917999267578 or $1 (as of November 11, 2026 at 1:54 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹939.18 in Generate Biomedicines, Inc. stock (as per the Rupee-Dollar exchange rate as on November 11, 2026 at 1:54 am IST). Based on Generate Biomedicines, Inc. share’s latest price of $13.84 as on November 11, 2026 at 1:54 am IST, you will get 0.7225 shares of Generate Biomedicines, Inc.. Learn more about fractional shares .